Effects of sevoflurane with Remifentanil plus Propofol on recovery conditions

Comparison of the effects of sevoflurane with Remifentanil plus Propofol on recovery conditions in adolescent patient with movement disorders candidate for dental treatment under general anesthesia.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100621004224N38

Enrollment

Registered

2020-05-13

Start date

2020-05-26

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Movement disorders.

Interventions

Intervention 1: Intervention group: to maintain anesthesia, sevoflurane USP inhaled drug from Piramal Company is used. The drug is given to the patient at a dose of MAC: 1.85 through a tracheal tube w

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The desire to participate in the study Patients over 18 years of age Patients with movement disorders Patients are candidates for dental treatment under general anesthesia

Exclusion criteria

Exclusion criteria: People who are allergic to eggs or soy Known allergies Chronic diseases including heart disease, bleeding disorders, liver disease and kidney disease

Design outcomes

Primary

Measure	Time frame
Recovery score on "Nursing Delirium Screening Scale" Checklist. Timepoint: 5,10 and 15 minuts after entering recovery. Method of measurement: "Nursing Delirium Screening Scale" Checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaser Kaviani

Esfahan University of Medical Sciences

kaviani@dnt.mui.ac.ir+98 31 3673 3504

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026